Куба первой в мире начала вакцинацию от COVID-19 детей с 2 лет | Новости из Германии о событиях в мире | DW dw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dw.com Daily Mail and Mail on Sunday newspapers.
Peningkatan aktivitas di Pelabuhan Soekarno-Hatta, Makassar, membuat PT Pelindo IV (Persero) mencetak laba senilai Rp138,37 miliar di semester I/2021. Perolehan itu lebih tinggi 31,2 persen dibandingkan dengan capaian di periode sama tahun lalu.
Abu Erupsi Gunung Sinabung Selimuti 4 Kabupaten/Kota se-Sumut tribunnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribunnews.com Daily Mail and Mail on Sunday newspapers.
Published: Apr 19, 2021
BEVERLY HILLS, Calif., April 19, 2021 /PRNewswire/ GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company s proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, reported financial results for the fourth quarter and year ended December 31, 2020. 2020 was a year of robust clinical progress and milestone achievements for GT Biopharma, which allowed us to accomplish a major corporate milestone in listing GT Biopharma on NASDAQ at the beginning of 2021. The emerging data from our GTB-3550 TriKE™ program in hematological malignancies, MDS and AML, are encouraging in both safety and efficacy profiles. The ongoing data profile has demonstrated significant differences from all other NK cell therapies and NK engager companies, making TriKE™ a monotherapy, off-the-shelf platform therapeutic. TriKE™ exerts its therapeu
GT Biopharma Reports Fourth Quarter and Year End 2020 Results and Business Update prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.